Published by Josh White on 7th December 2022
(Sharecast News) - Cancer therapy-focussed biotechnology company BiVictriX Therapeutics has identified a development lead for its 'BVX001' programme, it announced on Wednesday.
URL: http://www.digitallook.com/dl/news/story/33162381/...